Health in Uganda 1,224 indicators covering health for Uganda. IndicatorLatest Year10-yr change Rank Number of new leprosy cases with G2D among children 4 2024 — 15th Neonates protected at birth against neonatal tetanus (PAB) 81.0% 2022 down 4.7% 84th Prevalence of overweight, weight for height 3.4% 2022 down 41.4% 63rd Most sold brand of cigarettes - price in currency reported 4,000 2020 up 166.7% 12th Most sold brand of cigarettes - taxes as a % of price - total tax 0.3% 2020 down 22.2% 145th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 — 109th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 34th Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 42nd Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 down 53.3% 140th Most sold brand of cigarettes - taxes as a % of price - specific 0.3% 2020 down 3.4% 78th Most sold brand of cigarettes - price in US$ at official exchange 1.09 2020 up 65.2% 149th Number healthy diet unaffordable 35.60 million 2024 up 19.1% 15th Import of environmentally sound technologies 398.05 million 2020 up 47.6% 105th Percentage of people living with HIV who know their HIV status 94 2025 up 16.0% 21st Percentage of people living with HIV who know their status receiving 91 2025 up 42.2% 58th Most sold brand of cigarettes - price in PPP$ 2.97 2020 up 44.2% 144th Export of environmentally sound technologies 40.93 million 2020 up 40.8% 103rd Pcv3 number unvaccinated 146,164 2023 down 73.0% 28th Reported number of human rabies deaths 68 2024 up 195.7% 10th Proportion of births delivered in a health facility (Facility births) 73.4% 2016 up 78.6% 108th Number of non-autochthonous leprosy cases 24 2024 — 5th Prevalence of wasting, weight for height, female 2.7% 2022 down 27.0% 57th Prevalence of wasting, weight for height, male 3.8% 2022 down 20.8% 50th Number reported cases of cholera 173 2021 down 92.6% 26th Population with basic handwashing facilities at home 20.0% 2024 up 51.4% 84th Prevalence of severe wasting, weight for height, female 0.7% 2022 up 133.3% 48th Prevalence of severe wasting, weight for height, male 1.3% 2022 up 225.0% 37th Prevalence of overweight, weight for height, female 3.2% 2022 down 28.9% 55th Prevalence of overweight, weight for height, male 3.6% 2022 down 51.4% 55th HPV immunization coverage estimates among primary target cohort (9-14) 69.0% 2025 down 30.3% 65th Prevalence of underweight, weight for age, female 8.2% 2022 down 25.5% 50th Prevalence of underweight, weight for age, male 11.2% 2022 down 13.2% 46th Prevalence of stunting, height for age, female 21.6% 2022 down 32.9% 35th Prevalence of stunting, height for age, male 27.2% 2022 down 23.4% 28th How many health warnings are approved by the law for cigarette 4 2022 up 300.0% 105th Tuberculosis - new and relapse cases 46,306 2011 up 25.7% 20th Number of reported cholera deaths 0 2021 down 100.0% 37th Physiotherapists 669 2024 up 486.8% 61st Diarrhea treatment 46.7% 2016 up 17.9% 38th Pregnant women receiving prenatal care 95.1% 2019 up 1.0% 52nd Percentage of principal display area mandated to be covered by health 65 2022 up 116.7% 25th Average of 13 International Health Regulations core capacity scores 58.4 2017 up 62.2% 120th New cases: pulmonary smear-negative 11,487 2012 up 9.8% 25th Estimated number of pregnant women living with HIV needing 75,000 2025 down 10.7% 3rd Percentage of principal display area mandated to be covered by health 65 2022 up 116.7% 26th Percentage of principal display area mandated to be covered by health 65 2022 up 116.7% 30th Average death rate due to natural disasters 0.1723 2021 down 92.4% 82nd Number of full-time equivalent staff in national agency 2 2022 unchanged 78th Total number of notified TB cases 46,171 2014 up 3.5% 21st The number of people with susceptibility test result for rifampicin 28,418 2021 — 11th Estimated number of pregnant women living with HIV 100 2025 unchanged 1st New cases: pulmonary smear unknown/not done 1,783 2012 down 71.5% 12th Smear-positive tuberculosis treatment-success rate 77.0% 2011 up 37.5% 116th Share of one year olds who received the rotavirus vaccine 86 2024 up 138.9% 42nd Insufficiently active 85.67 2016 down 0.3% 44th The number of people with susceptibility test result for rifampicin 74.76 2021 — 101st Contraceptive prevalence, any method 41.4% 2022 up 75.4% 31st Number of presumed malaria cases 573,813 2024 down 90.9% 8th Contraceptive prevalence, any modern method 34.7% 2022 up 67.7% 29th Number of indigenous malaria cases 12.73 million 2024 up 71.7% 3rd ← Previous Page 16 of 21 Next →